D-0426-2017 Class III Terminated

Recalled by Pharm D Solutions, LLC — Houston, TX

FDA drug recall D-0426-2017 was initiated by Pharm D Solutions, LLC on Oct 12, 2016 and is designated Class III. Reason for recall: Incorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states "in grapeseed oil" instead of "in sesame oil" . The primary panel is correct The recall status is terminated (terminated May 11, 2017). Affected quantity: 4 mL: 510 vials, 5 mL: 486 vials.

Recall details

Product Type
Drugs
Report Date
Jan 18, 2017
Initiation Date
Oct 12, 2016
Termination Date
May 11, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 mL: 510 vials, 5 mL: 486 vials

Product description

Testosterone Cypionate 200 mg/mL in Sesame Oil, 4 mL and 5 mL vials, Rx only, For IM injection, Pharm D Solutions, Loop West Houston, TX --- NDA 69699-1709-04

Reason for recall

Incorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states "in grapeseed oil" instead of "in sesame oil" . The primary panel is correct

Distribution pattern

AZ and WA

Code information

Lot: 09122016:34, exp 09/07/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0426-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0426-2017. Report a data issue: hello@regdatalab.com.